Skip to main content

Table 4 Responses on barriers in using EBM (No., %)

From: Awareness, attitudes, barriers, and knowledge about evidence-based medicine among family physicians in Croatia: a cross-sectional study

Statement

Family medicine specialist

Family doctor

Total

P-valuea

There is not enough evidence relevant for family medicine practice

 Not a barrier

78 (54.2)

49 (38.6)

127 (54)

0.844

 Significant barrier

61 (60.4)

40 (39.6)

101 (43)

 Very significant barrier

5 (71.4)

2 (28.6)

7 (3)

Patients request treatments that have no proven medical efficacy

 Not a barrier

53 (68.8)

24 (31.2)

77 (32.8)

0.234

 Significant barrier

64 (56.6)

49 (43.4)

113 (48.1)

 Very significant barrier

27 (60)

18 (40)

45 (19.1)

I do not have enough skills for finding evidence

 Not a barrier

81 (64.3)

45 (35.7)

126 (53.4)

0.185

 Significant barrier

57 (61.3)

36 (38.7)

93 (39.4)

 Very significant barrier

7 (41.2)

10 (58.8)

17 (7.2)

I do not have enough time for finding evidence

 Not a barrier

29 (63)

17 (37)

46 (19.7)

0.036

 Significant barrier

88 (67.2)

43 (32.8)

131 (56)

 Very significant barrier

27 (47.4)

30 (52.6)

57 (24.4)

I do not have enough skills for critical assessment of evidence

 Not a barrier

58 (63)

34 (37)

92 (39.5)

0.112

 Significant barrier

79 (64.2)

44 (35.8)

123 (52.8)

 Very significant barrier

7 (38.9)

11 (61.1)

18 (7.7)

I do not have enough time for reading and assessment of evidence

 Not a barrier

35 (70)

15 (30)

50 (21.2)

0.325

 Significant barrier

82 (60.3)

54 (39.7)

136 (57.6)

 Very significant barrier

28 (56)

22 (44)

50 (21.2)

I do not have enough skills in presenting results of relevant research to my patients

 Not a barrier

69 (63.9)

39 (36.1)

108 (46)

0.722

 Significant barrier

62 (59.6)

42 (40.4)

104 (44.3)

 Very significant barrier

13 (56.5)

10 (43.5)

23 (9.8)

I do not have enough time to discuss research results with my patients during their scheduled appointment with me

 Not a barrier

32 (71.7)

13 (28.9)

45 (19.1)

0.308

 Significant barrier

76 (60.8)

49 (39.2)

125 (53.2)

 Very significant barrier

37 (56.9)

28 (43.1)

65 (27.7)

The use of EBM will further limit the number of patients that I can examine at my medical office

 Not a barrier

66 (66.7)

33 (33.3)

99 (42.1)

0.150

 Significant barrier

66 (60)

44 (40)

110 (46.8)

 Very significant barrier

12 (46.2)

14 (53.8)

26 (11.1)

Despite the results of relevant studies, patients have unrealistic expectations that influence my choice of treatment

 Not a barrier

47 (71.2)

19 (28.8)

66 (28.2)

0.05

 Significant barrier

71 (60.7)

46 (39.3)

117 (50)

 Very significant barrier

25 (49)

26 (51)

51 (21.8)

I am concerned about the financial aspects of my practice because the access to EBM sources is costly

 Not a barrier

64 (79)

17 (21)

81 (34.4)

< 0.001

 Significant barrier

52 (56.5)

40 (43.5)

92 (39)

 Very significant barrier

29 (46)

34 (54)

63 (26.7)

  1. aχ2-test